Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Cost-effectiveness of Lung Cancer Screening in Canada. 26226181 Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK JAMA Oncol 2015 NLST
Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. 26199983 Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D Am. J. Respir. Crit. Care Med. 2015 NLST
Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. 25837734 Fitzgerald NR, Flanagan WM, Evans WK, Miller AB, Canadian Partnership against Cancer (CPAC) Cancer Risk Management (CRM) Lung Cancer Working Scand J Work Environ Health 2015 NLST
Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. 26372542 Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ Cancer 2015 NLST
Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. 26356134 Balekian AA, Fisher JM, Gould MK Chest 2015 NLST
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. 26502000 Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA Am. J. Respir. Crit. Care Med. 2015 NLST
Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. 26712960 Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER Oncologist 2015 NLST
Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. 26602092 Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V Urol. Oncol. 2015 NLST, PLCO
Data Processing and Analytic Support in the PLCO Cancer Screening Trial. 26238116 Mabie J, Riley T, Marcus PM, Black A, Rozjabek H, Yu K, Young M, Austin J, Rathmell J, Williams C, Prorok PC Rev Recent Clin Trials 2015 PLCO
The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. 26238115 Gohagan JK, Prorok PC, Greenwald P, Kramer BS Rev Recent Clin Trials 2015 NLST, PLCO
The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource. 26238117 Carrick DM, Black A, Gohagan JK, Khan A, Pettit K, Williams C, Yu K, Yurgalevitch S, Huang WY, Zhu C Rev Recent Clin Trials 2015 PLCO
Comprehensive Quality Management (CQM) in the PLCO Trial. 26238118 Gohagan JK, O'Brien B, Hasson MA, Umbel KD, Bridgeman B, Kramer BS, Reding D, Gren L, Wright P, Riley T, Prorok PC Rev Recent Clin Trials 2015 PLCO
Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 26238119 Miller AB, Feld R, Fontana R, Gohagan JK, Jatoi I, Lawrence W, Miller A, ProroK PC, Rajput A, Sherman M, Welch G, Wright P, Yurgalevitch S, Albertsen P Rev Recent Clin Trials 2015 PLCO
Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center. 26238206 Gren LH, Lamerato LE, Wright P, Marcus PM Rev Recent Clin Trials 2015 PLCO
Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial. 26238207 Bazzi L, Lamerato LE, Varner J, Shambaugh VL, Cordes JE, Ragard LR, Marcus PM Rev Recent Clin Trials 2015 PLCO
Building Successful Relationships in the PLCO Cancer Screening Trial. 26238208 Marcus PM, Broski KG, Buys SS, Childs J, Church TR, Gohagan JK, Gren LH, Higgins D, Jaggi R, Jenkins V, Johnson CC, Lappe K, O'Brien B, Ogden SL, Prorok PC, Reding D, Shambaugh V, Yokochi LA, Yurgalevitch S Rev Recent Clin Trials 2015 PLCO
Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. 26291054 Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang ZF, La Vecchia C Br. J. Cancer 2015 PLCO
Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial. 26291583 Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D JAMA Oncol 2015 PLCO
Finasteride Reduces Risk of Bladder Cancer in a Large Prospective Screening Study. 26320383 Morales EE, Grill S, Svatek RS, Kaushik D, Thompson IM, Ankerst DP, Liss MA Eur. Urol. 2015 PLCO
Focused Decision Support: a Data Mining Tool to Query the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Dataset and Guide Screening Management for the Individual Patient. 26385814 Sharma A, Hostetter J, Morrison J, Wang K, Siegel E J Digit Imaging 2015 PLCO